newsfilter
← Latest News
Business Wire·

Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform

Multi-year global collaboration will leverage Guardant's tissue and liquid biopsy portfolio to support clinical development and companion diagnostic strategies Guardant Health, Inc. (NASDAQ:GH), a leading precision